Labcorp Holdings Inc. (LH) — Analysis Summary
Labcorp Holdings Inc. (LH) has a market cap of $27.29B with year-over-year revenue growth of +7.2%. Net margin stands at 6.3%. The stock trades at a P/E ratio of 27.2.
Key Takeaways
- Revenue changed +7.2% year-over-year
- Net margin of 6.3%
- P/E ratio of 27.2
Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, LH posted revenue growth of +7.2% and trades at a P/E of 27.2.
Labcorp Holdings Inc. (LH)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Sector
SERVICES-MEDICAL LABORATORIES
Employees
71,000
Headquarters
BURLINGTON, NC
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$2.88
Dividend Yield
0.86%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.